Effect of drugs on adrenergic nerve terminals.
D000588:Amines / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001369:Axons / Q000187:drug effects; D001949:Bretylium Compounds / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology; D066298:In Vitro Techniques; D008566:Membranes / Q000187:drug effects; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009411:Nerve Endings / Q000187:drug effects* / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000378:metabolism; D009538:Nicotine / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D012018:Reflex / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D013439:Sulfhydryl Reagents / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000187:drug effects*; D013565:Sympatholytics / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects; D014439:Tyramine / Q000037:antagonists & inhibitors
D000588:Amines; D000928:Antidepressive Agents; D001949:Bretylium Compounds; D008996:Monoamine Oxidase Inhibitors; D018377:Neurotransmitter Agents; D013439:Sulfhydryl Reagents; D013565:Sympatholytics; D009538:Nicotine; D012110:Reserpine; D003891:Desipramine; D009638:Norepinephrine; D014439:Tyramine; D006145:Guanethidine